Scientists report developing a broad-spectrum bird flu vaccine designed to work against a wide range of influenza variants. Euronews says the approach uses AI to design the vaccine and frames it as a potential shift for biosecurity and more resilient public health preparedness.
Medical Xpress adds that researchers from the University of Cambridge describe the vaccine as outperforming stockpiled shots, citing animal-trial results. It says the AI-guided method has produced a third success for vaccines targeting highly infectious viruses that can affect both animals and humans, and that the new vaccine provides complete protection against diverse, globally circulating bird flu variants in those trials.
Across the coverage, the common emphasis is on the AI-driven design and the broad coverage of variants, with differing framing: Euronews focuses on public health and biosecurity implications, while Medical Xpress highlights performance compared with existing stockpiled vaccines and the specific animal-trial outcome.